Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules targeting central nervous system disorders and metabolic diseases. Its rigid cyclobutane scaffold with a trifluoromethyl group enhances metabolic stability and membrane permeability, making it valuable in medicinal chemistry for optimizing drug candidates. Commonly employed in the preparation of enzyme inhibitors and receptor modulators where fluorinated amines improve binding affinity and pharmacokinetic profiles.